Lupin receives approval from U.S. FDA for Topiramate Extended-Release Capsules EP News Bureau Jul 15, 2024 The company to market a generic equivalent of Trokendi XR Extended-Release Capsules
VNS and cenobamate combo therapy success paves way for cenobamate monotherapy, says GlobalData EP News Bureau Jul 9, 2024 The combination therapy demonstrated significant improvements in seizure control, highlighting its potential as a safe and…
Exploring new avenues to treat Alzheimer’s Dr Devendra Kumar, Mar 11, 2024 Dr Devendra Kumar, Assistant Professor, NMIMS SPTM Shirpur shares details of his study In funded by the ICMR. He informs that his…
Akums gets DCGI approval for Perampanel Oral Suspension EP News Bureau Jun 27, 2023 This approval allows Perampanel Oral Suspension to serve as adjunctive therapy for treatment of partial-onset seizures (POS) with…
Zydus gets USFDA nod for Acetazolamide Tablets USP, 125 mg and 250 mg EP News Bureau Apr 6, 2023 Acetazolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision.…
Granules India gets ANDA approval for Gabapentin tablets EP News Bureau Mar 29, 2023 Gabapentin tablets are indicated for management of postherpetic neuralgia in adults; and as an adjunctive therapy in the treatment…
Zydus Cadila gets tentative US FDA approval for Brivaracetam tablets EP News Bureau Jun 14, 2021 Brivaracetam is used to treat partial-onset of seizures (epilepsy)
Alkem launches anti-epileptic drug BRIVASURE (Brivaracetam) EP News Bureau Mar 15, 2021 Brivaracetam has shown promise in patients with epilepsy whose seizures persist despite adequate treatment.
NATCO launches Brivaracetam tablets in India EP News Bureau Feb 26, 2021 Brivaracetam is indicated towards treatment of epilepsy.
Sun Pharma to launch entire range of Brivaracetam for epilepsy treatment in India EP News Bureau Feb 23, 2021 Brivaracetam is an anti-epileptic drug (AEDs) with fast onset of action and promising efficacy